IL6 and graft versus host disease: Notably, NK cells exhibit low graft versus host disease (GvHD) potential and rarely induce significant toxicities due to limited persistence in the body, lack of T-cell receptors, decreased CRS especially IL-6, and safety of allogenic NK cells, making them a promising platform for CAR engineering.